Ensem Therapeutics Inc, a Boston-based biotechnology company, has raised $67 million in funding. The company’s backers include GGV Capital and Pavilion Capital.
Source: Press Release
Ensem Therapeutics nabs $67m
Ensem Therapeutics Inc, a Boston-based biotechnology company, has raised $67 million in funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: